Literature DB >> 18302111

Oocyte quality in adult polycystic ovary syndrome.

Satin S Patel1, Bruce R Carr.   

Abstract

Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility in women. Folliculogenesis in the PCOS ovary is often disrupted, leading to suboptimal oocyte competence for fertilization. This alteration in oocyte development is likely due to intrinsic molecular defects in the oocyte along with the state of androgen excess in PCOS patients. Many therapeutic options are available to infertile couples with PCOS, including controlled ovarian hyperstimulation and in vitro fertilization. However, because of immature oocytes, many patients are not able to conceive using standard infertility treatments. The advent of in vitro maturation may allow patients an alternative option by which to achieve conception. This review is intended to describe the mechanisms of aberrant folliculogenesis and their impact on fertility in the PCOS patient.

Entities:  

Mesh:

Year:  2008        PMID: 18302111     DOI: 10.1055/s-2008-1042958

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  19 in total

1.  Defining the role of bariatric surgery in polycystic ovarian syndrome patients.

Authors:  Shaveta M Malik; Michael L Traub
Journal:  World J Diabetes       Date:  2012-04-15

Review 2.  A Narrative Review of Placental Contribution to Adverse Pregnancy Outcomes in Women With Polycystic Ovary Syndrome.

Authors:  Angela S Kelley; Yolanda R Smith; Vasantha Padmanabhan
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

3.  Spindle and chromosome configurations of in vitro-matured oocytes from polycystic ovary syndrome and ovulatory infertile women: a pilot study.

Authors:  Rodolpho C Vieira; Ionara D Barcelos; Elisa M Ferreira; Wellington P Martins; Rui A Ferriani; Paula A Navarro
Journal:  J Assist Reprod Genet       Date:  2010-09-04       Impact factor: 3.412

Review 4.  Pathology of hyperandrogenemia in the oocyte of polycystic ovary syndrome.

Authors:  Neil R Chappell; William E Gibbons; Chellakkan S Blesson
Journal:  Steroids       Date:  2022-02-18       Impact factor: 2.668

5.  Impact of metabolic disorders on endometrial receptivity in patients with polycystic ovary syndrome.

Authors:  Can Wang; Yang-Xing Wen; Qing-Yun Mai
Journal:  Exp Ther Med       Date:  2022-01-14       Impact factor: 2.447

Review 6.  Polycystic ovarian syndrome and miscarriage in IVF: systematic revision of the literature and meta-analysis.

Authors:  Roberto Matorras; Jose Ignacio Pijoan; Lucía Laínz; María Díaz-Nuñez; Héctor Sainz; Silvia Pérez-Fernandez; Dayana Moreira
Journal:  Arch Gynecol Obstet       Date:  2022-09-04       Impact factor: 2.493

7.  Downregulation of both gene expression and activity of Hsp27 improved maturation of mouse oocyte in vitro.

Authors:  Jin-Juan Liu; Xiang Ma; Ling-Bo Cai; Yu-Gui Cui; Jia-Yin Liu
Journal:  Reprod Biol Endocrinol       Date:  2010-05-14       Impact factor: 5.211

Review 8.  Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence.

Authors:  Jie Qiao; Huai L Feng
Journal:  Hum Reprod Update       Date:  2010-07-16       Impact factor: 15.610

Review 9.  The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment?

Authors:  Norbert Gleicher; Andrea Weghofer; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2011-08-17       Impact factor: 5.211

10.  Embryos from polycystic ovary syndrome patients with hyperandrogenemia reach morula stage faster than controls.

Authors:  Neil Ryan Chappell; Maya Barsky; Jaimin Shah; Mary Peavey; Liubin Yang; Haleh Sangi-Haghpeykar; William Gibbons; Chellakkan Selvanesan Blesson
Journal:  F S Rep       Date:  2020-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.